MedPath

To assess the effectiveness of an Ayurvedic formulation Gomutra Haritaki in improving iron deficiency status in anemia(Pandu Roga)

Phase 3
Conditions
Health Condition 1: E638- Other specified nutritional deficiencies
Registration Number
CTRI/2021/03/031701
Lead Sponsor
Chaudhary Brahm Prakash Ayurved Charak Sansthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients between the age group 18 and 60 years

Patients having any five or more amongst the cardinal symptoms of Pandu Roga i.e

1. Karnswead (tinitus)

2. Hatanal (suppression of the power of digestion)

3. Sadan (prostration)

4. Anndwesh (repugnance against food)

5. Daurbalyta (Weakness)

6. Shrama (fatigue)

7. Gatrashool (pain in body)

8. Jwara (fever)

9. Shwasa (exertional dyspnoea),

10. Gaurav (heaviness)

11. Aruchi (Loss of Appetite)

12. Shunakshikuta Shotha (Oedema around Eyes)

13. Harita (greenish complexion)

14. Shirnaloma (fall of small body hairs)

15. Hritprabha (loss of bodyâ??s lusture)

16. Kopana (becomes irritating)

17. Shishirdweshi (dislikes cold things)

18. Nidralu (excessive feeling of sleepiness)

19. Shthiwan (excessive spit)

20. Alpawak (avoid speaking)

21. Pindikodveshtana (cramp in calf muscle ),

22. Katiurupaadruksadan (while climbing suffer pain and weakness in lower limb,thigh,feet )

23. Hridspandanam (Palpitation)

24. Bhrama (vertigo),

Patients having Hb% less than 12 gm/dl and more than 8.00 gm/dl for females.

Patients having Hb% less than 13 gm/dl and more than 8.00 gm/dl for males

Exclusion Criteria

Patients suffering from systemic diseases like renal disorders, heart disease, cancer, acquired immunedeficiency syndrome, tuberculosis., hypertension, and having bleeding disorders

Any other type of anaemia except Iron Deficiency Anaemia.

Age <18 years and more than 60 years

Hb% level-below 8 gm/dl

Anaemia in a case of defective absorption due to gastrectomy, sprue syndrome etc.

Pregnant women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in the findings of serum ferritin. <br/ ><br>Timepoint: DAY1 <br/ ><br>DAY45 <br/ ><br> <br/ ><br>DAY45 <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Clinical improvement in the clinical feature of Iron Deficiency Anemia. <br/ ><br>Improvement in haemoglobin concentration. <br/ ><br>Timepoint: DAY1 <br/ ><br>DAY30 <br/ ><br>DAY45
© Copyright 2025. All Rights Reserved by MedPath